Epinephrine Injection Market

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
Epinephrine Injection Market contains market size and forecasts of Epinephrine Injection in Global, including the following market information:
Global Epinephrine Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Epinephrine Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epinephrine Auto-injector Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epinephrine Injection include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Epinephrine Injection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Injection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Epinephrine Injection Market Segment Percentages, by Type, 2021 (%)
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Global Epinephrine Injection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Epinephrine Injection Market Segment Percentages, by Application, 2021 (%)
Anaphylaxis
Cardiac Arrest
Others
Global Epinephrine Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Epinephrine Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epinephrine Injection revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Epinephrine Injection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group